pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
raps·1d ago·1 min read
save

Former FDA chief Califf calls for regulatory overhaul and predicts AI assistants in future oversight

Sep 17, 2026·read at raps ↗RegulatoryNeutral

Robert Califf, who served as FDA commissioner, reflected on his early experience as a medical student in the 1970s working with a pioneering patient database that tracked cardiovascular procedures over a lifetime.

He argued that the current regulatory framework is outdated and needs to be modernized to keep pace with scientific and technological advances.

Califf also highlighted the potential role of artificial intelligence assistants in future regulatory processes, suggesting they could help streamline reviews and improve decision making.

source

This writeup was produced by pharmadog from original reporting by raps.

Original headline: “Convergence: Califf says regulations ‘need an update,’ sees AI assistants in regulatory future”

read at raps ↗
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Cardiology2

related stories

  • May 2Opinion: STAT readers on MAHA activists, perimenopause, and diversity in medical schoolSTAT
  • Apr 30Remembering J. Craig Venter: a relentless scientist who changed biotech — and was all too easily misunderstoodSTAT
  • Apr 30STAT+: In her own words: Surgeon general nominee Nicole Saphier expresses enthusiasm and caution for MAHASTAT
  • Apr 30Trump drops Casey Means as surgeon general nominee, opts for radiologist Nicole SaphierSTAT
  • Apr 30STAT+: Pharmalittle: We’re reading about a Supreme Court hearing on ‘skinny labels,’ AstraZeneca U.K. expansion, and moreSTAT